186 related articles for article (PubMed ID: 26920557)
1. Antagonistic Activity of Nocardia brasiliensis PTCC 1422 Against Isolated Enterobacteriaceae from Urinary Tract Infections.
Jalali HK; Salamatzadeh A; Jalali AK; Kashani HH; Asbchin SA; Issazadeh K
Probiotics Antimicrob Proteins; 2016 Mar; 8(1):41-5. PubMed ID: 26920557
[TBL] [Abstract][Full Text] [Related]
2. Etiology and antimicrobial susceptibility pattern of bacterial pathogens from urinary tract infection.
Khatri B; Basnyat S; Karki A; Poudel A; Shrestha B
Nepal Med Coll J; 2012 Jun; 14(2):129-32. PubMed ID: 23671963
[TBL] [Abstract][Full Text] [Related]
3. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
Akram M; Shahid M; Khan AU
Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
Bouchillon SK; Badal RE; Hoban DJ; Hawser SP
Clin Ther; 2013 Jun; 35(6):872-7. PubMed ID: 23623624
[TBL] [Abstract][Full Text] [Related]
5. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010.
Maraki S; Mantadakis E; Michailidis L; Samonis G
J Microbiol Immunol Infect; 2013 Jun; 46(3):202-9. PubMed ID: 22795650
[TBL] [Abstract][Full Text] [Related]
6. Resistance pattern of enterobacteriaceae isolates from urinary tract infections to selected quinolones in Yaoundé.
Lyonga EE; Toukam M; Nkenfou C; Gonsu HK; Assoumou MC; Mesembe MT; Eyoh AB; Ikomey GM; Ndze VN; Koulla-Shiro S
Pan Afr Med J; 2015; 21():105. PubMed ID: 26327943
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
Demir T; Buyukguclu T
Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
Jean SS; Coombs G; Ling T; Balaji V; Rodrigues C; Mikamo H; Kim MJ; Rajasekaram DG; Mendoza M; Tan TY; Kiratisin P; Ni Y; Weinman B; Xu Y; Hsueh PR
Int J Antimicrob Agents; 2016 Apr; 47(4):328-34. PubMed ID: 27005459
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
Cuevas O; Cercenado E; Gimeno M; Marín M; Coronel P; Bouza E;
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):251-60. PubMed ID: 20542206
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley.
Tantry BA; Rahiman S
West Indian Med J; 2012 Oct; 61(7):703-7. PubMed ID: 23620968
[TBL] [Abstract][Full Text] [Related]
11. The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy.
Ishikawa K; Matsumoto T; Yasuda M; Uehara S; Muratani T; Yagisawa M; Sato J; Niki Y; Totsuka K; Sunakawa K; Hanaki H; Hattori R; Terada M; Kozuki T; Maruo A; Morita K; Ogasawara K; Takahashi Y; Matsuda K; Hirose T; Miyao N; Hayashi T; Takeyama K; Kiyota H; Tomita M; Yusu H; Koide H; Kimura S; Yanaoka M; Sato H; Ito T; Deguchi T; Fujimoto Y; Komeda H; Asano Y; Takahashi Y; Ishihara S; Arakawa S; Nakano Y; Tanaka K; Fujisawa M; Matsui T; Fujii A; Yamamoto S; Nojima M; Higuchi Y; Ueda Y; Kanamaru S; Monden K; Tsushima T; Seno Y; Tsugawa M; Takenaka T; Hamasuna R; Fujimoto N; Sho T; Takahashi K; Inatomi H; Takahashi N; Ikei Y; Hayami H; Yamane T; Nakagawa M; Kariya S; Arima T
J Infect Chemother; 2011 Feb; 17(1):126-38. PubMed ID: 21174142
[TBL] [Abstract][Full Text] [Related]
12. Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland.
Stefaniuk E; Suchocka U; Bosacka K; Hryniewicz W
Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1363-9. PubMed ID: 27189078
[TBL] [Abstract][Full Text] [Related]
13. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
Sader HS; Farrell DJ; Flamm RK; Jones RN
J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
[TBL] [Abstract][Full Text] [Related]
14. Effect of the 2014 Clinical and Laboratory Standards Institute urine-specific breakpoints on cefazolin susceptibility rates at a community teaching hospital.
Chastain DB; Ngando I; Bland CM; Franco-Paredes C; Hawkins WA
Ann Clin Microbiol Antimicrob; 2017 May; 16(1):43. PubMed ID: 28558707
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance among uropathogens responsible for community-acquired urinary tract infections in an Italian community.
Miragliotta G; Di Pierro MN; Miragliotta L; Mosca A
J Chemother; 2008 Dec; 20(6):721-7. PubMed ID: 19129070
[TBL] [Abstract][Full Text] [Related]
16. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
Matute AJ; Hak E; Schurink CA; McArthur A; Alonso E; Paniagua M; Van Asbeck E; Roskott AM; Froeling F; Rozenberg-Arska M; Hoepelman IM
Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.
García-Rodríguez JA; Trujillano Martín I; Baquero F; Cisterna R; Gobernado M; Liñares F; Martín-Luengo F; Piédrola G
J Chemother; 1997 Dec; 9(6):394-402. PubMed ID: 9491838
[TBL] [Abstract][Full Text] [Related]
18. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Martinez P; Garzón D; Mattar S
Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1983). I. Susceptibility distribution].
Kosakai N; Igari J; Kumamoto Y; Sakai S; Shigeta S; Shiraiwa Y; Abe K; Tazaki H; Iri H; Uchida H
Jpn J Antibiot; 1985 Aug; 38(8):2185-229. PubMed ID: 4079003
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
